Obesity continues to be a prevalent concern, as it is the leading cause for multiple comorbidities, chronic medical conditions, cancers, and worker’s compensation injuries.
A program designed with an added focus on goals and additional strategies to address obesity as a disease takes a proactive approach toward improving the health of a population. **T-Rx: TrestleTree’s** **Obesity Rx Program** is built on a two-pronged approach: behavior change-driven lifestyle modification and appropriate use of anti-obesity medication therapy.
For this program, TrestleTree integrates behavior change coaching (e.g., nutrition, exercise, stress, medication adherence) with anti-obesity medication utilization to achieve, optimize, and sustain weight loss alongside positive disease state outcomes.
By targeting the at-risk population, TrestleTree aims to achieve and maintain relationships with participants to promote clinically meaningful and sustainable weight loss that ultimately reduces disease burden and health care spend.
Join us to learn how this program has been implemented at Pfizer in this case study.
* Treating Obesity as a chronic condition
* Solutions for Obesity in the Workplace (T-Rx, or “Health Weight” by T-Rx in Pfizer language)
* Why Pfizer investing in such a program?
* Program construct key elements
* Implementation best practices
For more information contact Glenn Garrison glenn.garrison@trestletree.com
Town Hall Overview:
Obesity is a prevalent concern in today’s society, impacting both individual health and workplace performance. Pfizer, a leading pharmaceutical company known for its commitment to corporate wellness strategies, has taken an innovative approach to managing obesity in their employee population. In this blog post, we will dive into the details of Pfizer’s comprehensive program and explore the key elements that make it successful.
The Growing Concern of Obesity in the Workplace:
Obesity is not just a lifestyle condition, but a chronic medical condition that can lead to multiple comorbidities and increased healthcare costs. Pfizer recognizes the impact of obesity on their workforce and the need to address it as a disease. Chronic medical conditions, such as cancers and musculoskeletal issues, are top claim drivers for employers. By focusing on obesity, Pfizer aims to improve the overall health of their employees while reducing healthcare costs and productivity losses.
The Trestle Tree Obesity RX Program:
Pfizer has partnered with TrestleTree, a healthcare coaching company, to implement a unique program called the TrestleTree Obesity RX Program. This program takes a two-pronged approach, focusing on behavior change-driven lifestyle modification and the appropriate use of anti-obesity medication therapy. By combining these strategies, Pfizer aims to empower their employees to make sustainable behavior changes that contribute to weight loss and improved health outcomes.
Collaboration and Program Development:
One of the critical factors contributing to the success of Pfizer’s program is collaboration. Working closely with TrestleTree and other healthcare providers, Pfizer developed a comprehensive program tailored to their employee population’s needs. By leveraging their existing partnerships and networks, Pfizer ensured access to specialized obesity experts, coaches, and medical opinions. This collaboration allowed for a seamless integration of the program into Pfizer’s existing ecosystem.
Implementation and Communication Strategies:
Implementing a program of this scale requires effective communication and engagement strategies. Pfizer adopted a multi-faceted approach, ensuring that their employees received timely and relevant information about the program. Using a combination of emails, flyers, alerting clinicians, and even targeted mailings, Pfizer successfully reached their employees through various channels. They also utilized their recently launched benefits website to provide easy access to program details and resources.
Monitoring and Reporting Outcomes:
A crucial aspect of this program is measuring its outcomes and impact on the employee population. Pfizer aims to analyze the total cost of care for the program’s participants compared to non-participants and individuals with comorbidities. By monitoring clinical outcomes, participation rates, and member experiences, Pfizer can assess the program’s success and the value it brings to their employees and the organization as a whole.
Pfizer’s commitment to addressing obesity in the workplace through their TrestleTree Obesity RX Program is commendable. By taking a comprehensive approach, focusing on behavior change and appropriate use of anti-obesity medication therapy, Pfizer aims to empower their employees to achieve sustainable weight loss and improved health outcomes. Through collaboration, effective communication, and outcome monitoring, Pfizer demonstrates their dedication to the well-being of their workforce. This program serves as an inspiration for other employers looking to tackle obesity and promote healthier lives for their employees.
